Big Bad Pharma

Middlewood Studio · 2026 · $6.99 · Simulation · deal grade A

Measured on 2026-09-24 04:52 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $3.4k to $5.0k per month
Opportunity: $5.5k per month at x1.30 dormancy
Estimated lifetime owners: 4.1k
84% positive across 105 reviews · 71.6 reviews/month

Why it's flagged

Developer active, last post 0 months ago
Store page localized in only 1 language(s)
Last discounted 0 months ago, 2 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-09-01; the live figures above take precedence over any numbers in it.

A cozy pharmacy-shelf-organizing simulation by a solo developer, launched January 2026, with 10,000+ medication items to sort and categorize.

Big Bad Pharma is a freshly launched, genuinely niche title in the organizing-game genre with a devoted early adopter base (81% positive, 90% still playing). The solo developer demonstrates active stewardship: removed AI-generated assets post-launch, patches bugs rapidly, and engages with feedback. Current residuals are modest but stable; the real opportunity lies in targeted quality-of-life fixes (item readability, upgrade economy tuning, visual clarity) that could unlock stronger retention and word-of-mouth. Best suited for a publishing or partnership play, not acquisition, given the creator's evident indie commitment. Most realistic play: publishing.

Risk: Early build instability: inventory desync bugs, shelf-placement logic inconsistencies, and UI hover-state quirks are cited repeatedly and require debugging attention.
Risk: Organizing-game genre is crowded and trend-sensitive; differentiation relies on visual and mechanical polish, neither of which is fully realized yet.
Risk: Solo-developer capacity: scaling content or support while maintaining quality and dev health is a known constraint in indie-studio partnerships.

This case as Markdown · Estimates carry ±30-50% error per title.